Miami Office
701 Waterford Way, Suite 340
Miami, FL 33126
Phone: (305) 712-7177
The U.S. Drug Enforcement Administration (DEA) has published its final rule that places a more restrictive classification on hydrocodone combination products (HCPs) (Vicodin, Lortab, Lorcet,
The first contact to a defendant in a healthcare fraud case is usually by way of a Grand Jury target letter. This letter informs you that
If your DEA renewal application is not received prior to the expiration of your DEA registration, you will not be allowed to handle controlled substances, and you may
If you’re a Florida pharmacist working with large-scale commercial retail pharmacies, you’d best be on alert: Recently, there has been a disturbing trend regarding pharmacists
In 2022, prosecutors charged a pharmacy owner with $14.5 million Medicare kickbacks. They alleged they paid kickbacks to telemarketing …….
A routine pharmacy audit revealed a couple of inconsistencies. A false positive drug test put our clients career in jeopardy, and risk of….
Provider faced an investigation due to an alleged diversion of facility medication and a subsequent employer ordered positive drug screen.
Our Florida healthcare attorneys provided clearly showed that the healthcare fraud allegations were improper, and the case was dismissed.
Our Florida healthcare attorneys provided FL DOH with medical records, including info on an insurance audit, to prove there was no fraud.
Our Healthcare Compliance lawyers negotiated with the DEA for over a year to avoid order to show cause and retain a pharmacist’s license.
Our attorneys argued to the OIG that exclusion for the prescribed time period was unreasonable under OIG regulations, and that most factors that would lead to a greater exclusion period were inapplicable.
Our Medicare fraud attorneys obtained a reinstatement of billing privileges for a laboratory audited for billing for unnecessary services where there were alleged “credible allegations of fraud.”
We successfully demonstrated to the DEA that the pharmacist had the financial capacity to operate a pharmacy and also fully understood his corresponding responsibilities in regarding to narcotic medication dispensing and record keeping.
Miami Office
701 Waterford Way, Suite 340
Miami, FL 33126
Phone: (305) 712-7177
The U.S. Drug Enforcement Administration (DEA) has published its final rule that places a more restrictive classification on hydrocodone combination products (HCPs) (Vicodin, Lortab, Lorcet,
The first contact to a defendant in a healthcare fraud case is usually by way of a Grand Jury target letter. This letter informs you that
If your DEA renewal application is not received prior to the expiration of your DEA registration, you will not be allowed to handle controlled substances, and you may
If you’re a Florida pharmacist working with large-scale commercial retail pharmacies, you’d best be on alert: Recently, there has been a disturbing trend regarding pharmacists
